427 related articles for article (PubMed ID: 19027358)
21. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
Carrel AL; Allen DB
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
[TBL] [Abstract][Full Text] [Related]
22. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
23. Sleep in children with autistic spectrum disorder: a questionnaire and polysomnographic study.
Miano S; Bruni O; Elia M; Trovato A; Smerieri A; Verrillo E; Roccella M; Terzano MG; Ferri R
Sleep Med; 2007 Dec; 9(1):64-70. PubMed ID: 17728182
[TBL] [Abstract][Full Text] [Related]
24. NREM sleep instability changes following rapid maxillary expansion in children with obstructive apnea sleep syndrome.
Miano S; Rizzoli A; Evangelisti M; Bruni O; Ferri R; Pagani J; Villa MP
Sleep Med; 2009 Apr; 10(4):471-8. PubMed ID: 18753006
[TBL] [Abstract][Full Text] [Related]
25. Distinctive polysomnographic traits in nocturnal frontal lobe epilepsy.
Parrino L; De Paolis F; Milioli G; Gioi G; Grassi A; Riccardi S; Colizzi E; Terzano MG
Epilepsia; 2012 Jul; 53(7):1178-84. PubMed ID: 22578113
[TBL] [Abstract][Full Text] [Related]
26. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
Höybye C
Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
[TBL] [Abstract][Full Text] [Related]
27. Sleepwalking, a disorder of NREM sleep instability.
Guilleminault C; Kirisoglu C; da Rosa AC; Lopes C; Chan A
Sleep Med; 2006 Mar; 7(2):163-70. PubMed ID: 16459139
[TBL] [Abstract][Full Text] [Related]
28. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy?
Vandeleur M; Davey MJ; Nixon GM
J Paediatr Child Health; 2013 Mar; 49(3):238-41. PubMed ID: 23438058
[TBL] [Abstract][Full Text] [Related]
29. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
[TBL] [Abstract][Full Text] [Related]
30. Developmental trends of sleep-disordered breathing in Prader-Willi syndrome: the role of obesity.
Hertz G; Cataletto M; Feinsilver SH; Angulo M
Am J Med Genet; 1995 Mar; 56(2):188-90. PubMed ID: 7625443
[TBL] [Abstract][Full Text] [Related]
31. Sleep phenotypes of intellectual disability: a polysomnographic evaluation in subjects with Down syndrome and Fragile-X syndrome.
Miano S; Bruni O; Elia M; Scifo L; Smerieri A; Trovato A; Verrillo E; Terzano MG; Ferri R
Clin Neurophysiol; 2008 Jun; 119(6):1242-7. PubMed ID: 18417419
[TBL] [Abstract][Full Text] [Related]
32. Cyclic alternating pattern (CAP) alterations in narcolepsy.
Terzano MG; Smerieri A; Del Felice A; Giglia F; Palomba V; Parrino L
Sleep Med; 2006 Dec; 7(8):619-26. PubMed ID: 16740406
[TBL] [Abstract][Full Text] [Related]
33. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
34. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.
Miller J; Silverstein J; Shuster J; Driscoll DJ; Wagner M
J Clin Endocrinol Metab; 2006 Feb; 91(2):413-7. PubMed ID: 16317059
[TBL] [Abstract][Full Text] [Related]
35. Daytime sleepiness and REM abnormalities in Prader-Willi syndrome: evidence of generalized hypoarousal.
Vgontzas AN; Bixler EO; Kales A; Centurione A; Rogan PK; Mascari M; Vela-Bueno A
Int J Neurosci; 1996 Nov; 87(3-4):127-39. PubMed ID: 9003974
[TBL] [Abstract][Full Text] [Related]
36. Reduced NREM sleep instability in benign childhood epilepsy with centro-temporal spikes.
Bruni O; Novelli L; Luchetti A; Zarowski M; Meloni M; Cecili M; Villa M; Ferri R
Clin Neurophysiol; 2010 May; 121(5):665-71. PubMed ID: 20097604
[TBL] [Abstract][Full Text] [Related]
37. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
[TBL] [Abstract][Full Text] [Related]
38. GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children.
Hauffa BP; Petersenn S
Clin Endocrinol (Oxf); 2009 Jul; 71(1):155-6. PubMed ID: 19178506
[No Abstract] [Full Text] [Related]
39. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
Höybye C; Hilding A; Marcus C; Thorén M
Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.
Carrel AL; Moerchen V; Myers SE; Bekx MT; Whitman BY; Allen DB
J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
